Antigua and Barbuda vs Georgia: HIV-positive TB patients on ART (antiretroviral therapy)
Antigua and Barbuda
100.0%
in 2022
Georgia
100.0%
in 2024
Antigua and Barbuda rank
1st
Georgia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Antigua and Barbuda
- Georgia
How they compare
Antigua and Barbuda currently reports 100.0% against 100.0% in Georgia, a difference of 0.0%.
The two have swapped places 1 time across 9 shared years of data; in 2004 it was Georgia ahead.
Antigua and Barbuda ranks 1st and Georgia ranks 1st of 144 countries.
Antigua and Barbuda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 84.3% | 15.7% | Antigua and Barbuda |
| 2010s | 100.0% | 84.0% | 16.0% | Antigua and Barbuda |
| 2020s | 100.0% | 83.0% | 17.0% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Antigua and Barbuda or Georgia?
- Antigua and Barbuda, at 100.0% against 100.0% in Georgia as of 2022.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Antigua and Barbuda and Georgia?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Georgia?
- 9 years are reported by both, from 2004 to 2022.
- How do Antigua and Barbuda and Georgia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Antigua and Barbuda ranks 1st and Georgia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.